161 related articles for article (PubMed ID: 21134563)
1. Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up.
Akyildiz HY; Mitchell J; Milas M; Siperstein A; Berber E
Surgery; 2010 Dec; 148(6):1288-93; discussion 1293. PubMed ID: 21134563
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
Berber E; Flesher N; Siperstein AE
World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases.
Cheng J; Glasgow RE; O'Rourke RW; Swanstrom LL; Hansen PD
Surg Endosc; 2003 Jan; 17(1):61-7. PubMed ID: 12360376
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of malignant liver tumors using microwave and radiofrequency ablation].
Popescu I; Sîrbu-Boeţi MP; Tomulescu V; Ciurea S; Boroş M; Hrehoreţ D; Jemna C
Chirurgia (Bucur); 2005; 100(2):111-20. PubMed ID: 15957451
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases.
Leblanc F; Fonck M; Brunet R; Becouarn Y; Mathoulin-Pélissier S; Evrard S
Eur J Surg Oncol; 2008 Feb; 34(2):185-90. PubMed ID: 17998155
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes.
Suppiah A; White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Hartley JE; Monson JR
Dig Surg; 2007; 24(5):358-60. PubMed ID: 17785980
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.
Henn AR; Levine EA; McNulty W; Zagoria RJ
AJR Am J Roentgenol; 2003 Oct; 181(4):1005-10. PubMed ID: 14500219
[TBL] [Abstract][Full Text] [Related]
12. [Radiofrequency ablation of liver tumors: technique and preliminary results].
Graur F; Vlad L; Furcea L; Miclăuş D; Osian G
Chirurgia (Bucur); 2006; 101(2):159-67. PubMed ID: 16752682
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency ablation in primary and secondary liver tumors].
Carditello A; Scisca C; David A; Stilo F; Basile M
Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
[TBL] [Abstract][Full Text] [Related]
16. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous radiofrequency ablation of hepatic neoplasms using a "cluster" electrode--first clinical results].
Trübenbach J; König CW; Duda SH; Schick F; Huppert PE; Claussen CD; Pereira PL
Rofo; 2000 Nov; 172(11):905-10. PubMed ID: 11142123
[TBL] [Abstract][Full Text] [Related]
18. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
19. Aggressive surgery for metastatic liver neuroendocrine tumors.
Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
[TBL] [Abstract][Full Text] [Related]
20. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer.
Basdanis G; Michalopoulos A; Papadopoulos V; Tzeveleki I; Efthimiadis Ch; Kosmidis Ch; Mekras D; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s187-9. PubMed ID: 15655617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
